<Disease><Name>[TREATMENT/THERAPY]: VALPROIC ACID [EXTERNAL]</Name><Synonym /><OMIM><Number /><URL /></OMIM><Orphanet><Number /><URL /></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene /><ICD /><Summary>Valproic acid; (VPA) is a widely used anticonvulsant drug which affects mitochondrial metabolism including the catabolism of fatty ;acids; and branched-chain amino ;acids. ;3-hydroxyisovaleric acid (3OH-IVA), one secondary metabolite of the leucine pathway, were significantly elevated in human urine after VPA treatment [Luis PB et al. 2012]</Summary><Symptoms><symtomp><id>3925</id><symptom>hyponatremia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1571</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>3.20</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1621</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>44.00</min><max>300.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1710</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>18.00</min><max>33.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1766</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>87.00</min><max>1900.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1944</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>122.00</min><max>550.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1945</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>166.00</min><max>330.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>1946</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>130.00</min><max>400.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>2054</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2138</id><name>Sodium</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>220.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>610</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>612</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>613</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>1567</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.60</min><max>6.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>86</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>10.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1320</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>7.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>609</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>4.10</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>611</id><name>2-Methyl-3-hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>2</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>66.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>517</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>43.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>518</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>54.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>524</id><name>3-Hydroxyisovaleric acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>49.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>397</id><name>3-Hydroxyisovaleric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>19.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>398</id><name>3-Hydroxyisovaleric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>18.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1225</id><name>3-Hydroxyisovalerylcarnitine (C5-OH)</name><specimen>blood</specimen><value>increased</value><min>0.05</min><max>0.31</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1226</id><name>3-Hydroxyisovalerylcarnitine (C5-OH)</name><specimen>serum</specimen><value>increased</value><min>0.09</min><max>0.53</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>36</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>210.00</min><max>743.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>830</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>110.00</min><max>356.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>862</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>283.00</min><max>1097.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1414</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>180.00</min><max>1633.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>1-7d</comment></metabolite><metabolite><id>1909</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>64.00</min><max>236.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1910</id><name>Glycine</name><specimen>urine</specimen><value>increased</value><min>43.00</min><max>173.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>35</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>230.00</min><max>500.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>474</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>1.90</min><max>10.00</max><unit>&#956;mol/l</unit><age>3m-10years</age><method /><comment /></metabolite><metabolite><id>977</id><name>Glycine</name><specimen>plasma</specimen><value>increased</value><min>100.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>738</id><name>Glycine</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.02</min><max>0.04</max><unit>ratio</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1272</id><name>Glycine</name><specimen>blood</specimen><value>increased</value><min>85.10</min><max>536.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1273</id><name>Glycine</name><specimen>serum</specimen><value>increased</value><min>144.67</min><max>911.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>409</id><name>Sodium</name><specimen>serum</specimen><value>normal/dec</value><min>134.00</min><max>146.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>413</id><name>Sodium</name><specimen>serum</specimen><value>normal/dec</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>728</id><name>Sodium</name><specimen>sweat</specimen><value>normal/dec</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1105</id><name>Sodium</name><specimen>serum</specimen><value>normal/dec</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6121</id><title>Severe Hyponatremia Due to Valproic Acid Toxicity</title><author>Gupta E,</author><journal>J Clin Med Res</journal><year>2015</year><book /><volume>7</volume><number>9</number><pages>717-719</pages><co_aut>Kunjal R, Cury JD</co_aut></literature><literature><id>6131</id><title>Amino acids</title><author>Pasquali M, Longo N</author><journal>In: Nenad Blau N, Duran M, Gibson KM, Dionisi-Vici C (eds) Physician&#8217;s guide to the laboratory diagnosis of metabolic diseases. Springer, Berlin/Heidelberg/New York</journal><year>2014</year><book /><volume>0</volume><number>0</number><pages>752</pages><co_aut /></literature><literature><id>6120</id><title>Inhibition of 3-methylcrotonyl-CoA carboxylase explains the increased excretion of 3-hydroxyisovaleric acid in valproate-treate</title><author>Luis PB,</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>3</number><pages>443-449</pages><co_aut>et al.</co_aut></literature><literature><id>6122</id><title>Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study</title><author>Price KE,</author><journal>Clin Pharmacol Ther</journal><year>2011</year><book /><volume>89</volume><number>6</number><pages>867-874</pages><co_aut>et al.</co_aut></literature><literature><id>6123</id><title>Valproic acid utilizes the isoleucine breakdown pathway for its complete &#946;-oxidation</title><author>Luis PB,</author><journal>Biochem Pharmacol</journal><year>2011</year><book /><volume>82</volume><number>11</number><pages>1740-1746</pages><co_aut>et al.</co_aut></literature><literature><id>6130</id><title>Amino acid analysis</title><author>Shih VE</author><journal>In: Blau N, Duran M, Blaskovics ME, Gibson KM (eds) Physician&#8217;s guide to the laboratory diagnosis of metabolic disease</journal><year>2003</year><book /><volume>0</volume><number>0</number><pages>11-26</pages><co_aut /></literature><literature><id>6187</id><title>Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS</title><author>Silva MF,</author><journal>Clin Biochem. 2001 Nov;34(8):635-8.</journal><year>2001</year><book /><volume>34</volume><number>8</number><pages>635-638</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>